iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC trimmed its position in iRhythm Technologies, Inc. (NASDAQ:IRTC) by 4.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 23,541 shares of the company’s stock after selling 1,069 shares during the period. Mutual of America Capital Management LLC owned approximately 0.08% of iRhythm Technologies worth $2,520,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Covestor Ltd lifted its stake in shares of iRhythm Technologies by 285.2% during the third quarter. Covestor Ltd now owns 312 shares of the company’s stock worth $29,000 after buying an additional 231 shares during the period. Lazard Asset Management LLC acquired a new stake in shares of iRhythm Technologies during the third quarter worth $38,000. Nisa Investment Advisors LLC lifted its stake in shares of iRhythm Technologies by 110.3% during the third quarter. Nisa Investment Advisors LLC now owns 574 shares of the company’s stock worth $54,000 after buying an additional 301 shares during the period. Point72 Hong Kong Ltd acquired a new stake in shares of iRhythm Technologies during the second quarter worth $85,000. Finally, International Assets Investment Management LLC acquired a new stake in shares of iRhythm Technologies during the fourth quarter worth $92,000.

Insider Buying and Selling at iRhythm Technologies

In other iRhythm Technologies news, insider Patrick Michael Murphy sold 7,615 shares of iRhythm Technologies stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $121.96, for a total value of $928,725.40. Following the completion of the transaction, the insider now owns 48,962 shares of the company’s stock, valued at $5,971,405.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, EVP Daniel G. Wilson sold 1,261 shares of iRhythm Technologies stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $121.96, for a total value of $153,791.56. Following the sale, the executive vice president now owns 32,967 shares in the company, valued at $4,020,655.32. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Patrick Michael Murphy sold 7,615 shares of iRhythm Technologies stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $121.96, for a total transaction of $928,725.40. Following the completion of the sale, the insider now owns 48,962 shares in the company, valued at approximately $5,971,405.52. The disclosure for this sale can be found here. Over the last quarter, insiders sold 35,052 shares of company stock valued at $4,274,942. Corporate insiders own 0.43% of the company’s stock.

Analysts Set New Price Targets

IRTC has been the subject of several research reports. Needham & Company LLC lifted their price objective on shares of iRhythm Technologies from $136.00 to $137.00 and gave the stock a “buy” rating in a research note on Friday, February 23rd. Canaccord Genuity Group raised their target price on shares of iRhythm Technologies from $121.00 to $133.00 and gave the stock a “buy” rating in a report on Friday, February 23rd. Truist Financial raised their target price on shares of iRhythm Technologies from $115.00 to $133.00 and gave the stock a “buy” rating in a report on Friday, December 22nd. Finally, JPMorgan Chase & Co. reduced their target price on shares of iRhythm Technologies from $142.00 to $133.00 and set an “overweight” rating for the company in a report on Friday, February 23rd. One investment analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $135.11.

iRhythm Technologies Stock Down 0.0 %

IRTC opened at $112.09 on Friday. iRhythm Technologies, Inc. has a fifty-two week low of $70.24 and a fifty-two week high of $140.23. The company has a debt-to-equity ratio of 0.17, a quick ratio of 2.02 and a current ratio of 2.15. The company has a fifty day moving average of $111.45 and a two-hundred day moving average of $101.20. The stock has a market capitalization of $3.49 billion, a price-to-earnings ratio of -27.68 and a beta of 1.30.

iRhythm Technologies (NASDAQ:IRTC) last released its quarterly earnings data on Thursday, February 22nd. The company reported ($1.26) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.66). iRhythm Technologies had a negative net margin of 25.05% and a negative return on equity of 56.38%. The firm had revenue of $132.51 million during the quarter, compared to analysts’ expectations of $131.14 million. On average, research analysts expect that iRhythm Technologies, Inc. will post -3.14 earnings per share for the current year.

iRhythm Technologies Company Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.